JPS5527908B2 - - Google Patents

Info

Publication number
JPS5527908B2
JPS5527908B2 JP3937577A JP3937577A JPS5527908B2 JP S5527908 B2 JPS5527908 B2 JP S5527908B2 JP 3937577 A JP3937577 A JP 3937577A JP 3937577 A JP3937577 A JP 3937577A JP S5527908 B2 JPS5527908 B2 JP S5527908B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3937577A
Other languages
Japanese (ja)
Other versions
JPS52151178A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS52151178A publication Critical patent/JPS52151178A/ja
Publication of JPS5527908B2 publication Critical patent/JPS5527908B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9
    • C07D219/12Amino-alkylamino radicals attached in position 9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
JP3937577A 1976-04-06 1977-04-06 Production of 11nitroo99 dialkylaminoisoalkylamino acridine and salts thereof Granted JPS52151178A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL1976188528A PL101032B1 (pl) 1976-04-06 1976-04-06 Sposob otrzymywania 1-nitro-9-dwualkilo-aminoizoalkiloamiroakrydyn lub ich soli

Publications (2)

Publication Number Publication Date
JPS52151178A JPS52151178A (en) 1977-12-15
JPS5527908B2 true JPS5527908B2 (enExample) 1980-07-24

Family

ID=19976296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3937577A Granted JPS52151178A (en) 1976-04-06 1977-04-06 Production of 11nitroo99 dialkylaminoisoalkylamino acridine and salts thereof

Country Status (12)

Country Link
US (1) US4150231A (enExample)
JP (1) JPS52151178A (enExample)
BE (1) BE852855A (enExample)
CH (1) CH634561A5 (enExample)
DE (1) DE2713103C2 (enExample)
FR (1) FR2347350A1 (enExample)
GB (1) GB1579588A (enExample)
HU (1) HU173105B (enExample)
NL (1) NL7703680A (enExample)
PL (1) PL101032B1 (enExample)
SE (1) SE435712B (enExample)
SU (2) SU683617A3 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335244A (en) * 1979-11-30 1982-06-15 Bristol-Myers Company Monolactate salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide
JPS56127370A (en) * 1980-02-15 1981-10-06 Mitsui Toatsu Chem Inc Novel piperazine compound, its preparation and utilization
PL126407B1 (en) * 1980-04-23 1983-07-30 Politechnika Gdanska Process for preparing 1-nitro-9-hydroxyalkylaminoacridines or their salts
HU186383B (en) * 1981-02-27 1985-07-29 Biogal Gyogyszergyar Process for producing new citostatic amni-acridie-alpha, beta-bracket-d-bracket closed, or aracket-l-bracket closed-n-glycoside derivatives and salts
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
US4626540A (en) * 1983-11-08 1986-12-02 Warner-Lambert Company Substituted 1-amino-4-nitro-acridinones and methods of treating bacterial infections and leukemia with them
DE3582995D1 (de) * 1984-10-25 1991-07-04 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
US6589961B2 (en) 2000-02-18 2003-07-08 New York Medical College 9-alkylamino-1-nitroacridine derivatives
DE60143020D1 (de) * 2000-02-18 2010-10-21 New York Medical College Valha 9-alkylamino-1-nitroacridin-derivate
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
CA2608144C (en) 2005-04-28 2012-11-13 Proteus Biomedical, Inc. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1962277A (en) * 1927-01-11 1934-06-12 Winthrop Chem Co Inc Basic nitroderivatives of 9-aminoacridines and process for preparing the same
DE1620473C3 (de) * 1964-05-25 1980-03-20 Starogardzkie Zaklady Farmaceutyczne Polfa Przedsiebiorstwo Panstwowe, Starogard Gdanski (Polen) Verfahren zur Herstellung von 1 -Nitro-9-(3'-dimethylaminopropylamino)-acridin-dihydrochlorid
US3897435A (en) * 1968-08-31 1975-07-29 Starogadzkie Zaklady Farmaceut N-oxides of 1 -nitro-9-dialkylaminoalkylamino/acridine
CH517096A (de) * 1968-08-31 1971-12-31 Starogardzkie Zakl Farma Verfahren zur Herstellung neuer, biologisch aktiver 1-Nitro-9-(dialkyl-aminoalkylamino)-akridin-N10-oxide

Also Published As

Publication number Publication date
US4150231A (en) 1979-04-17
SU683617A3 (ru) 1979-08-30
DE2713103A1 (de) 1977-10-13
HU173105B (hu) 1979-02-28
FR2347350A1 (fr) 1977-11-04
BE852855A (fr) 1977-07-18
NL7703680A (nl) 1977-10-10
SU682127A3 (ru) 1979-08-25
SE435712B (sv) 1984-10-15
FR2347350B1 (enExample) 1980-02-01
CH634561A5 (de) 1983-02-15
GB1579588A (en) 1980-11-19
SE7703979L (sv) 1977-10-07
PL101032B1 (pl) 1978-11-30
DE2713103C2 (de) 1982-02-04
JPS52151178A (en) 1977-12-15

Similar Documents

Publication Publication Date Title
FI770073A7 (enExample)
DK573676A (enExample)
DE2760070A1 (enExample)
DK141391C (enExample)
FI770074A7 (enExample)
JPS5527908B2 (enExample)
DK142661C (enExample)
FI760880A7 (enExample)
DK138437C (enExample)
DE2656815C3 (enExample)
DK138768C (enExample)
DE2624252C3 (enExample)
FI53235B (enExample)
DK140535C (enExample)
DK140324C (enExample)
DK343077A (enExample)
DK98277A (enExample)
FI760867A7 (enExample)
FI762160A7 (enExample)
FI763748A7 (enExample)
CH601782A5 (enExample)
CH607242A5 (enExample)
CH614557A5 (enExample)
CH615796B (enExample)
DD124264A5 (enExample)